Aphria (NYSE:APHA) Trading Down 8.4%

Share on StockTwits

Aphria Inc (NYSE:APHA) shares were down 8.4% during mid-day trading on Tuesday . The company traded as low as $4.87 and last traded at $4.99, approximately 14,706,008 shares were traded during mid-day trading. An increase of 108% from the average daily volume of 7,057,570 shares. The stock had previously closed at $5.45.

A number of equities analysts recently issued reports on APHA shares. Jefferies Financial Group set a $8.30 price target on Aphria and gave the company a “buy” rating in a report on Tuesday, October 15th. Pi Financial set a $9.00 price target on Aphria and gave the company a “buy” rating in a report on Tuesday, October 15th. ValuEngine downgraded Aphria from a “buy” rating to a “hold” rating in a report on Thursday, December 5th. Cantor Fitzgerald started coverage on Aphria in a report on Tuesday, November 5th. They issued an “overweight” rating and a $10.40 price target for the company. Finally, Zacks Investment Research downgraded Aphria from a “strong-buy” rating to a “hold” rating in a report on Monday, January 6th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and six have issued a buy rating to the company. Aphria presently has an average rating of “Buy” and a consensus price target of $12.03.

The stock has a fifty day moving average of $4.93 and a 200-day moving average of $5.62. The stock has a market capitalization of $1.24 billion, a price-to-earnings ratio of -45.36 and a beta of 2.78.

Aphria (NYSE:APHA) last issued its quarterly earnings data on Tuesday, October 15th. The company reported $0.07 earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.03) by $0.10. The firm had revenue of $126.10 million during the quarter, compared to analysts’ expectations of $131.15 million. The company’s quarterly revenue was up 848.1% compared to the same quarter last year. Equities analysts predict that Aphria Inc will post 0.06 earnings per share for the current fiscal year.

Hedge funds and other institutional investors have recently modified their holdings of the business. Ladenburg Thalmann Financial Services Inc. lifted its stake in Aphria by 153.2% in the second quarter. Ladenburg Thalmann Financial Services Inc. now owns 39,336 shares of the company’s stock valued at $277,000 after buying an additional 23,800 shares during the last quarter. Barclays PLC lifted its stake in Aphria by 87.9% in the third quarter. Barclays PLC now owns 47,677 shares of the company’s stock valued at $248,000 after buying an additional 22,305 shares during the last quarter. ETF Managers Group LLC purchased a new stake in Aphria in the second quarter valued at approximately $48,941,000. Cambridge Investment Research Advisors Inc. purchased a new stake in Aphria in the third quarter valued at approximately $254,000. Finally, LPL Financial LLC lifted its stake in Aphria by 57.3% in the second quarter. LPL Financial LLC now owns 61,291 shares of the company’s stock valued at $430,000 after buying an additional 22,316 shares during the last quarter. Institutional investors own 9.60% of the company’s stock.

Aphria Company Profile (NYSE:APHA)

Aphria Inc produces and sells medical cannabis in Canada and internationally. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It serves patients and health professionals. The company also sells its products online. Aphria Inc is headquartered in Leamington, Canada.

Recommended Story: Most Volatile Stocks – What Investors Need to Know to Maximize ROI

Receive News & Ratings for Aphria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aphria and related companies with MarketBeat.com's FREE daily email newsletter.